Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Inspecs Group Plc ( (GB:SPEC) ) is now available.
Inspecs Group plc reported a 2.9% decrease in revenue for the first half of 2025 due to uncertainties surrounding US tariffs, but anticipates a return to growth in the second half with a strong order book and strategic market expansions. The company is also in discussions to sell its subsidiary, Norville, and is in the process of appointing a new Independent Non-Executive Chair, reflecting its ongoing strategic adjustments to enhance operational efficiency and market positioning.
Spark’s Take on GB:SPEC Stock
According to Spark, TipRanks’ AI Analyst, GB:SPEC is a Neutral.
The overall stock score is primarily impacted by financial performance struggles and negative technical indicators. The valuation is notably weak due to a negative P/E ratio and absence of dividend yield. However, positive corporate events provide some support by indicating potential for improved leadership alignment and governance stability.
To see Spark’s full report on GB:SPEC stock, click here.
More about Inspecs Group Plc
INSPECS Group plc is a prominent global provider of eyewear solutions, offering a wide array of products including eyewear frames, low vision aids, and lenses. The company operates under both branded and OEM models, with a focus on increasing its own-brand portfolio and expanding its global distribution network. INSPECS has a significant presence worldwide, with operations in the UK, Germany, Portugal, Scandinavia, the US, and China, and manufacturing facilities in Vietnam, China, the UK, and Italy.
Average Trading Volume: 313,761
Technical Sentiment Signal: Strong Sell
Current Market Cap: £44.23M
Find detailed analytics on SPEC stock on TipRanks’ Stock Analysis page.